{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:03Z","timestamp":1794047403673,"version":"4.8.0"},"reference-count":76,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Follicular lymphoma is a heterogeneous B-cell lymphoma both in presentation and at progression. For most patients it is a chronic, relapsing indolent disease with overall survival expectations now potentially beyond 20 years. However, in a significant minority (~20%) who experience early progression or histological transformation after treatment, the disease no longer has an indolent behavior. This review looks at the development of prognostic indices, staging and therapies for follicular lymphoma, identifying where the data can, and cannot, guide the multidisciplinary team to determine an individualized approach to first-line therapy. A nuanced patient- and disease-specific approach is necessary to maximize disease response and survival while minimizing therapeutic toxicity.<\/jats:p>","DOI":"10.3324\/haematol.2021.278766","type":"journal-article","created":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T05:20:43Z","timestamp":1641014443000},"page":"7-18","source":"Crossref","is-referenced-by-count":30,"title":["Time for an individualized approach to first-line management of follicular lymphoma"],"prefix":"10.3324","volume":"107","author":[{"given":"Guillaume","family":"Cartron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Trotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"32713","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70027-0"},{"key":"32714","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01073"},{"key":"32715","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00400"},{"key":"32716","unstructured":"National Cancer Institute Surveillance Epidemiology and End Results Program. Cancer stat facts: NHL-follicular lymphoma. 2020. Publisher Full Text|"},{"key":"32717","unstructured":"Defossez G, Le Guyader-Peyrou S, Uhry Z. Estimations nationales de l'incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018 - Volume 1 : Tumeurs solides : \u00c9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim.Publisher Full Text|"},{"key":"32718","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgu006"},{"key":"32719","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0077"},{"key":"32720","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-008755"},{"key":"32721","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082842"},{"key":"32722","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12675"},{"key":"32723","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001091"},{"key":"32724","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-117235"},{"key":"32725","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004051"},{"key":"32726","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"32727","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.0736"},{"key":"32728","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2441-8"},{"key":"32729","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt137"},{"key":"32730","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.9440"},{"key":"32731","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124793"},{"key":"32732","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-816405"},{"key":"32733","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001261"},{"key":"32734","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.0934"},{"key":"32735","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(14)70008-0"},{"key":"32736","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30618-1"},{"key":"32737","doi-asserted-by":"publisher","DOI":"10.1002\/hon.110_2629"},{"key":"32738","doi-asserted-by":"publisher","DOI":"10.1002\/hon.35_2629"},{"key":"32739","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1110"},{"key":"32740","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14110-4"},{"key":"32741","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.7819"},{"key":"32742","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434"},{"key":"32743","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3991"},{"key":"32744","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00169-2"},{"key":"32745","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30102-5"},{"key":"32746","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24492"},{"key":"32747","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.1495"},{"key":"32748","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17404"},{"key":"32749","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00340-z"},{"key":"32750","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534"},{"key":"32751","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.12.006"},{"key":"32752","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621375"},{"key":"32753","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.7163"},{"key":"32754","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30090-5"},{"key":"32755","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a010720"},{"key":"32756","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-45"},{"key":"32757","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.6546"},{"key":"32758","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.9892"},{"key":"32759","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.05.013"},{"key":"32760","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30686-0"},{"key":"32761","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.5853"},{"key":"32762","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3411"},{"key":"32763","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.5376"},{"key":"32764","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.082412"},{"key":"32765","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4618"},{"key":"32766","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0016"},{"key":"32767","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003805.pub2"},{"key":"32768","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00262"},{"key":"32769","unstructured":"Kahl B, Burke J, van der Jagt R. Assessment of maintenance rituximab after first-line bendamustine-rituximab in patients with follicular lymphoma: an analysis from the BRIGHT trial. Blood. 2017; 130(Suppl 1):484."},{"key":"32770","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.0866"},{"key":"32771","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"32772","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00605"},{"key":"32773","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614598"},{"key":"32774","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805104"},{"key":"32775","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-115167"},{"key":"32776","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.8960"},{"key":"32777","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.008"},{"key":"32778","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.056"},{"key":"32779","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33660"},{"key":"32780","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100109"},{"key":"32781","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30251-9"},{"key":"32782","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00191-y"},{"key":"32783","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011568"},{"key":"32784","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2006.09.004"},{"key":"32785","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3198"},{"key":"32786","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100549"},{"key":"32787","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003797"},{"key":"32788","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/10486\/73951","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10486\/73952","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10486\/73951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:00:50Z","timestamp":1794045650000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/10486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.278766","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}